Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future

18 Jul 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hereditary Neurological Disorders
Share to Neurological diseases and metabolism
Share to Peripheral Neuropathies and Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32693030
DOI: 10.1016/j.trsl.2020.07.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the futurePMID 32693030Read ↗

Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth diseaseSemantic proximity Read ↗

Current Treatment Methods for Charcot–Marie–Tooth DiseasesSemantic proximity Read ↗

Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies.Semantic proximity Read ↗

Charcot-Marie-Tooth disease type 1A: mutational mechanisms and candidate gene.Semantic proximity Read ↗

The Current State of Charcot–Marie–Tooth Disease TreatmentSemantic proximity Read ↗

Charcot-Marie-Tooth: From Molecules to TherapySemantic proximity Read ↗

Update on Charcot–Marie–Tooth diseaseSemantic proximity Read ↗

The Current State of Charcot-Marie-Tooth Disease Treatment.Semantic proximity Read ↗

CMT1A current gene therapy approaches and promising biomarkersSemantic proximity Read ↗

Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future PerspectivesSemantic proximity Read ↗

Charcot-Marie-Tooth disease and pathways to molecular based therapies.Semantic proximity Read ↗

Phenotypic manifestations in French-Canadian populations with Charcot-Marie-Tooth disease type 1A associated with 17p11.2 duplication.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.